Available Technologies - Therapeutics

Docket No.

Title

UMA 09-34

<09-34>Biomarker-responsive Drug Delivery Systems for Controlled Release of Opioids and Opioid Antagonists

UMA 04-22

<04-22>DMBT1 as a Prognostic Tool for Assessing Breast Cancer Risk

UMA 07-23

<UMA 07-23>Using trg- Strains of Salmonella typhimurium as Targeted Bacterial Therapies

UMA 08-56

<08-56>A Multipurpose Microfluidic Device Designed to Mimic Microenvironment Gradients and Develop Targeted Cancer Therapeutics

UMA 04-14

Porous hydroxyapatite networks for synthetic bone material by spinodal decomposition

UMA 08-14

<UMA 08-14>Zero-Power Security for Implantable Medical Devices (IMD)

UMA 03-25

<UMA 03-25>Novel Polymer Capsules Prepared by Interfacial Crosslinking of Amphiphilic Graft Copolymers

UMA 03-22

Regulation of Acheron Expression

U.S. Patent #5,656,271

Oral Vaccine Comprising Anti-Idiotypic Antibody to Chlamydia Glycolipid Exoantigen and Process

U.S. Patent #5,840,297

Vaccine Comprising Anti-Idiotypic Antibody to Chlamydia GLXA and Process

U.S. Patent #6,090,911

<UMA 97-22>Reversible Hydrogels

UMA 98-04

<UMA 98-04>A New Vaccine for Protection of Children and Adults Against Schistosomiasis

UMA 04-19

<UMA 04-19>Quanitification of Chlamydia Infection through Flow Cytometry and Anti-Chlamydial Glycolipid Exoantigen (GLXA) Antibody